Boughton Soleil, an insider at Hims & Hers Health Inc (HIMS), sold 155,856 shares on November 9, 2025, at a price of $42.53 per share. The total transaction value reached $6.63 million. Following this sale, Soleil retains an equal number of shares in the company.
Hims & Hers Health operates a telehealth platform, connecting patients to licensed healthcare professionals for a range of treatments, including sexual health and mental health. The company, which went public on September 9, 2019, has a market capitalization of $9.3 billion and reported a P/E ratio of 48.25 with an EPS of 0.79.
Insider transactions are reported to the SEC, providing transparency into executive stock activities. While such sales can reflect personal financial decisions, they do not necessarily indicate a negative outlook on the company. Investors are advised to consider multiple insider transactions over time to gauge broader trends rather than focusing on isolated sales.